$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today

Artivion (NYSE:AORT) has outperformed the market over the past 20 years by 1.64% on an annualized basis producing an average annual return of 9.19%. Currently, Artivion has a market capitalization of $608.77 million.

Artivion (NYSE:AORT) has outperformed the market over the past 20 years by 1.64% on an annualized basis producing an average annual return of 9.19%. Currently, Artivion has a market capitalization of $608.77 million.

Buying $100 In AORT: If an investor had bought $100 of AORT stock 20 years ago, it would be worth $578.54 today based on a price of $15.10 for AORT at the time of writing.

Artivion’s Performance Over Last 20 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Genmab Announces FDA Acceptance For Priority Review Biologics License Application For Epcoritamab For The Treatment Of Relapsed/Refractory Large B-Cell Lymphoma

Epcoritamab BLA accepted for FDA Priority review; FDA action date is May 21, 2023 Epcoritamab could become the first subcutaneous bispecific antibody approved for the treatment of LBCL BLA submission supported by Epcoritamab BLA accepted for FDA Priority review; FDA action date is May 21, 2023

ABBV